Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Avalo Therapeutics, Inc. (AVTX) vs 4D Molecular Therapeutics, Inc. (FDMT)

Avalo Therapeutics, Inc. and 4D Molecular Therapeutics, Inc. are both Biotechnology companies. Avalo Therapeutics, Inc. and 4D Molecular Therapeutics, Inc. are of similar size ($843.1M and $807.1M). 4D Molecular Therapeutics, Inc. grew revenue faster over the last twelve months: 278,712.1% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −194.7%) and the higher return on invested capital (−118.2% vs −186.9%). Across the 18 metrics below, Avalo Therapeutics, Inc. leads on 10 and 4D Molecular Therapeutics, Inc. on 8.

Valuation

Metric AVTX FDMT Biotechnology median
P/E n/m n/m 7.88
P/S 540.92 11.05 11.47
P/B 1.50 2.49 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 221.48 7.34 10.73
Earnings yield (28.25%) (18.18%) (28.84%)
Free cash flow yield (20.63%) (15.34%) (23.03%)

Profitability

Metric AVTX FDMT Biotechnology median
Gross margin 64.72% 100.00% 65.16%
Operating margin 0.00% (214.24%) 0.00%
Net margin 0.00% (194.74%) 0.00%
Free cash flow margin 0.00% (169.51%) 0.00%
Return on equity (36.27%) (43.25%) (57.72%)
Return on assets (32.50%) (37.09%) (49.22%)
Return on invested capital (118.21%) (186.91%) 0.00%

Growth

Metric AVTX FDMT Biotechnology median
Revenue growth (TTM) (92.65%) 278,712.12% 5.64%
EPS growth (last fiscal year) (24.62%) 18.79% —
Revenue growth, 5-year CAGR (61.19%) 44.32% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVTX FDMT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 19.31 8.03 4.73
Net debt to EBITDA 1.36 2.52 0.96

Dividend

Metric AVTX FDMT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AVTX FDMT Biotechnology median
Market cap 843.06m 807.12m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack